Immune checkpoint inhibitor (ICI) responses have been attributed to several factors, such as tumor-infiltrating lymphocytes [10, 11], programmed cell death protein 1/programmed cell death protein ligand 1 expression [12, 13], tumor mutational burden [13, 14], tumor associated antigen expression [15], and gene expression profiles [16]. Here, PDCD1 is linked to neoplasm.